Global Artificial Intelligence in Diabetes Management Market: Drivers, Restraints, Opportunities, Trends, and Forecasts to 2023

Global Artificial Intelligence in Diabetes Management Market: Drivers, Restraints, Opportunities, Trends, and Forecasts to 2023

  • Report Code ID: RB90580
  • Category Healthcare
  • No. of Pages 82
  • Publication On Feb 2018
  • Publisher Name Infoholic Research
Artificial Intelligence in Diabetes Management Market - Global Drivers, Restraints, Opportunities, Trends, and Forecasts up to 2023
Market Overview
Diabetes is a major pervasive chronic ailment that extensively impacts the global population. It is a global epidemic and the most expensive disease. As per the Center for Disease Control and Prevention, the US alone incurs more than $245 billion a year in lost wages. Millions of people are afflicted with diabetes worldwide, and this number is rising at a rapid pace creating lucrative opportunities for companies and entrepreneurs. According to WHO statistics, nearly 422 million people globally have diabetes, and the number is accelerating at a burgeoning pace. One in 11 people must manage this chronic condition on a regular basis. The data-intensive nature of diabetes care and management makes it an ideal fit for applying artificial intelligence and machine learning to improve outcomes and find better solutions. Diabetes often has a debilitating effect on individuals resulting in strokes, heart attack, blindness, amputation, and kidney failure. Diabetes mellitus is a clinical condition in which an individual has elevated blood glucose levels. Insulin-dependent (type 1) diabetes is managed by monitoring the blood glucose level with finger prick blood tests performed several times throughout the day and adjusting insulin levels based on such readings. This invasive method is painful, inconvenient, time-consuming, and not good enough for managing a dynamic and complex disease condition such as diabetes. Several non-invasive methods of blood glucose measurement and insulin delivery are under development. Glucose measurement devices are now capable of continuously monitoring blood glucose levels throughout the day.
Digitization has made big data technologies more relevant in the healthcare context. The proliferation of smart devices has accelerated the transition to digitized healthcare. Smart apps have made self-management of diabetes by the patients affordable. Sensors are capable of transmitting data to the smart devices and diabetics can monitor their blood glucose levels on these devices. Pharmacogenetics and machine learning will help systems embedded with AI to manage diabetes better than humans within the next 20 years. AI algorithms bring about state-of-the-art glucose prediction methods that help in tackling diabetes effectively. They can mimic human cognitive functions. AI is leveraging the avalanche of healthcare data. AI is improving patient outcomes for diabetes patients. Data analytics is expected to make a disruptive impact in diabetes management. Machine learning algorithms enable better diagnosis and monitoring resulting in improved patient-centric treatment. Insulin trackers in the form of wearables, wristwatches, waistbands, and even pens can help in monitoring glucose levels in the blood. Portable and custom-made decision support systems for insulin dosing accumulate data from multiple sources such as manual inputs and body worn sensors. It is predicted that diabetes will extensively be managed by smart machines and AI algorithms within 20 years.
Market Analysis
According to Infoholic Research, the Global Artificial Intelligence in Diabetes Management market is expected to grow at a CAGR of 50.7% during the forecast period 2017-2023. The market is driven by factors such as rising elderly population, increasing obesity, favorable demographics, urbanization, rising healthcare costs, and increasing digital affinity. Patients privacy and security concerns, lack of curated datasets, and less digital savvy patients are few growth deterrents in the market. The market experiences few growth opportunities such as product innovations, democratization of knowledge, and rising prevalence of type 1 and type 2 diabetes.
Segmentation by Device Types
The market has been segmented and analyzed by the following device types: glucose monitoring devices, diagnostic devices, insulin delivery devices, and other devices.
Segmentation by Artificial Intelligence Techniques
The market has been segmented and analyzed by two artificial intelligence techniques namely case-based reasoning and intelligent data analysis.
Segmentation by Regions
The market has been segmented and analyzed by the following regions: North America, Europe, APAC, and LAMEA.
Segmentation by Countries
Each region has been further segmented and analyzed by countries:
North America - US and Canada
Europe - UK, Germany, Italy, and France
APAC - China, Japan, and India
LAMEA - GCC Countries, Mexico, and Africa
Benefits
The study covers and analyzes the Global Artificial Intelligence in Diabetes Management market. Bringing out the complete key insights of the industry, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, government initiatives, and technologies related to the market. In addition, it helps the venture capitalists in understanding the companies better and take informed decisions.
The report covers drivers, restraints, and opportunities (DRO) affecting the market growth during the forecast period (2017-2023).
It also contains an analysis of vendor profiles, which include financial health, business units, key business priorities, SWOT, strategies, and views.
The report covers competitive landscape, which includes M&A, joint ventures and collaborations, and competitor comparison analysis.
In the vendor profile section, for the companies that are privately held, financial information and revenue of segments will be limited.

Companies Mentioned

IBM Corporation Google Inc. Apple Inc. Apple Inc. Vodafone Group Plc.
Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Industry Trends 9
1.2.1 Trends in Diabetes Management 9
2 Report Outline 15
2.1 Report Scope 15
2.2 Report Summary 15
2.3 Research Methodology 15
2.4 Report Assumptions 16
3 Market Snapshot 16
3.1 Total Addressable Market (TAM) 16
3.2 Related Markets 17
4 Market Outlook 17
4.1 Overview 17
4.2 Regulatory Bodies & Standards 18
4.3 Political and Legal Implications in Diabetes Care 20
4.4 Economic Implications in Diabetes Care 20
4.5 Societal and Environmental Implications in Diabetes Care 21
4.6 Porter 5 (Five) Forces 21
4.7 Market Segmentation 23
4.8 Market Dynamics 23
4.8.1 Drivers 24
4.8.1.1 Favorable Demographics 24
4.8.1.2 Obesity Pandemic 25
4.8.1.3 Urbanization 25
4.8.1.4 Rising Healthcare Costs 25
4.8.1.5 Rising Digital Affinity 25
4.8.2 Restraints 27
4.8.2.1 Less Digital Savvy Patients 27
4.8.2.2 Patient Privacy and Data Security Concerns 27
4.8.2.3 Reimbursement and Cost Coverage Issues 27
4.8.2.4 Lack of Curated Data sets 27
4.8.3 Opportunities 27
4.8.3.1 Products Innovations 27
4.8.3.2 Rising Prevalence of Type 1 and Type 2 Diabetes 28
4.8.3.3 Growing usage of mobile technology in diabetes management 28
4.8.3.4 Democratization of Knowledge 28
4.8.4 DRO - Impact Analysis 30
5 Trends, Roadmap and Projects 31
5.1 Market Trends & Impact 31
5.2 Technology Roadmap 32
6 Device Types: Market Size & Analysis 33
6.1 Overview 33
6.1.1 Market Size and Analysis 33
6.2 Glucose Monitoring Devices 34
6.3 Diagnostic devices 35
6.4 Insulin Delivery Devices 35
7 Artificial intelligence Techniques: Market Size & Analysis 36
7.1 Overview 36
7.1.1 Intelligent Data Analysis 36
7.1.2 Case Based Reasoning 37
8 Geographic Segmentation: Market Size & Analysis 37
8.1 Overview 37
9 Global Generalist 49
9.1.1 IBM Corporation 49
9.1.1.1 Overview 49
9.1.1.2 Business units 51
9.1.1.3 Geographic revenue 53
9.1.1.4 IBM in Diabetes Management 54
9.1.1.5 Business focus 54
9.1.1.6 SWOT analysis 55
9.1.1.7 Business strategies 56
9.1.2 Google Inc. 57
9.1.2.1 Overview 57
9.1.2.2 Business units 59
9.1.2.3 Geographic revenue 60
9.1.2.4 Google in Diabetes Management 61
9.1.2.5 Business focus 61
9.1.2.6 SWOT analysis 61
9.1.2.7 Business strategies 62
9.1.3 Apple Inc. 63
9.1.3.1 Overview 63
9.1.3.2 Business units 64
9.1.3.3 Geographic revenue 66
9.1.3.4 Apple in Diabetes Management 67
9.1.3.5 Business focus 67
9.1.3.6 SWOT analysis 67
9.1.3.7 Business strategies 68
9.1.4 Vodafone Group Plc. 69
9.1.4.1 Overview 69
9.1.4.2 Business units 71
9.1.4.3 Geographic revenue 72
9.1.4.4 Vodafone in Diabetes Management 73
9.1.4.5 Business focus 73
9.1.4.6 SWOT analysis 73
9.1.4.7 Business strategies 74
10 Companies to Watch for 75
10.1 Diabnext 75
10.1.1 Overview 75
10.1.2 Diabnext Offerings 75
10.2 Glooko Inc. 76
10.2.1 Overview 76
10.2.2 76
10.2.3 Glukoo Offerings 76
10.2.4 Strategic Collaborations 77
10.3 Tidepool 77
10.3.1 Overview 77
10.3.2 77
10.3.3 Tidepool Offerings 77
11 Competitive Landscape 80
11.1 Competitor Comparison Analysis 80
12 Experts Views 81
Annexure 82
? Acronyms 82

List of Figures

Charts

CHART 2 RESEARCH METHODOLOGY 15
CHART 3 AI IN DIABETES MANAGEMENT MARKET REVENUE, 2016-2022 ($MILLION) 17
CHART 4 PORTERS 5 FORCES ON AI IN DIABETES MANAGEMENT MARKET 21
CHART 5 ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SEGMENTATION 23
CHART 6 MARKET DYNAMICS - DRIVERS, RESTRAINTS & OPPORTUNITIES 24
CHART 7 DRO - IMPACT ANALYSIS OF IOT HEALTHCARE MARKET 30
CHART 8 TECHNOLOGY ROADMAP FOR IOT HEALTHCARE MARKET 32
CHART 9 ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE BY DEVICE TYPES, 2016-2022 ($MILLION) 33
CHART 10 GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE BY GLUCOSE MONITORING DEVICES, 2016-2022 ($MILLION) 34
CHART 11 GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE BY DOAGNOSTIC DEVICES, 2016-2022 ($MILLION) 35
CHART 12 GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE BY INSULIN DELIVERY DEVICES, 2016-2022 ($MILLION) 35
CHART 13 GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE BY INTELLIGENT DATA ANALYSIS, 2016-2022 ($MILLION) 36
CHART 14 GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE BY CASE BASED REASONING, 2016-2022 ($MILLION) 37
CHART 33 IBM CORPORATION: OVERVIEW SNAPSHOT 49
CHART 34 IBM CORPORATION: BUSINESS UNITS 51
CHART 35 IBM CORPORATION: GEOGRAPHIC REVENUE 53
CHART 36 IBM CORPORATION: SWOT ANALYSIS 55
CHART 42 VODAFONE GROUP PLC.: OVERVIEW SNAPSHOT 69

?

List of Tables

Tables

TABLE 1 GLOBAL ARITFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE BY TYPE, 2016-2022 ($MILLION) 33
TABLE 2 BIOPHARMA MARKET REVENUE BY TYPE, 2016-2022 ($BILLION) 36
TABLE 3 ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE BY REGIONS, 2017-2023 ($MILLION) 38
TABLE 4 ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE IN NORTH AMERICA BY COUNTRIES, 2017-2023 ($MILLION) 39
TABLE 5 ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE IN EUROPE BY COUNTRIES, 2017-2023 ($MILLION) 41
TABLE 6 ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE IN APAC BY COUNTRIES, 2017-2023 ($MILLION) 44
TABLE 7 ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET REVENUE IN LAMEA BY COUNTRIES, 2017-2023 ($MILLION) 46

Related Products